DSG-34995-08606
2 vaccinations
4 coded responses
8 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 853 / AZ
- Registered
- 2021-01-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Dose 1 — Pfizer-BioNTech
-
2021-01-21
Registered in v-safe
-
2021-01-21
Dose 2 — Pfizer-BioNTech
- 2021-01-21
-
2021-01-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-01-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2021-02-11
Survey response — day 21, dose 2MedDRA: Nausea — Feeling: GoodFree text: NauseaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-20
Survey response — day 28, dose 2MedDRA: Nausea, Vomiting — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Nausea vomitingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-20
Report sent to call center — day 28, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-02-25
-
2021-03-06
Survey response — day 42, dose 2MedDRA: Nausea — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Worsening nauseaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-06
Report sent to call center — day 42, dose 2Be unable to do your normal daily activities1 call case(s)
-
2022-01-21
Survey response — 12 months, dose 2MedDRA: Diarrhoea — Feeling: FairFree text: Diarrhea. Had colonoscopyMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Pfizer-BioNTech | |
| 2 | 2021-01-21 | Pfizer-BioNTech |
Call center
2 call center cases
2 priority 2/3 (triaged and no follow up)
Free text
Release 4 — day 21, dose 2
Symptoms: Nausea
Release 4 — day 28, dose 2
Symptoms: Nausea vomiting
Release 5 — day 42, dose 2
Symptoms: Worsening nausea
Release 11 — 12 months, dose 2
Symptoms: Diarrhea. Had colonoscopy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diarrhoea | · | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Vomiting | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release